Aug 5, 2026
The pharmaceutical and biotech industries need machines that can do precise, complicated, multi-step processes. The solid phase reactor has become the standard for developing peptide drugs, cleaning up chiral intermediates, and doing cutting edge biopharmaceutical research. In contrast to traditional batch vessels, a solid phase reactor combines reaction, filtration, crystallization, and vacuum operations into a single, clear borosilicate glass body. This eliminates the need for expensive material transfers and the risk of cross-contamination. With more than 15 years of engineering experience, Xi'an Bioland Instrument Co., Ltd. makes sure that every solid phase reactor meets GMP/FDA standards and is certified by CE and ISO. They offer high-performance PTFE filtration assemblies, temperature control from -20 °C to 200 °C, and fully explosion-proof configurations. Bioland can make custom solutions for your lab, whether it needs a 20 L benchtop solid phase reactor or a 100 L pilot-scale system. They offer fast lead times, competitive prices, and full OEM/ODM support.
One of the fastest-growing areas of modern medicine is peptide therapy. However, increasing the amount of solid-phase peptide synthesis from milligrams to kilograms poses huge problems with how well the resin swells, the reagents are distributed, and the washing process works. A solid phase reactor designed just for this purpose solves these problems by combining a large-diameter PTFE filter disc with adjustable motion. This makes sure that the solvent contacts the whole resin bed evenly. After being exposed to DMF, DCM, TFA, and piperidine many times, the solid phase reactor's high-borosilicate glass body doesn't break down. It stays chemically inert through hundreds of coupling-deprotection cycles. Bioland's solid phase reactors can handle amounts ranging from 20 L to 100 L, so researchers can go from sequence tuning to experimental batch production without having to switch equipment platforms.
Thymosin peptides and antibacterial peptides need to be very pure, because even small amounts of impurities can make patients' immune systems react. The zero-metal-ion-contact design of the solid phase reactor makes it perfect for these uses. The GG17 borosilicate glass vessel and PTFE filtering parts make sure that no metallic contaminants get into the product stream. The solid phase reactor keeps the temperature under tight control at all times during the production of thymosin α1. This stops racemization and deletion sequences that could affect the end purity. Bioland engineers can add ultrasonic crystallization modules and nitrogen-blanketing ports to the solid phase reactor to make an oxygen-free space that is needed for making oxidation-sensitive peptide sequences on a pilot scale.
The solid phase reactor's full-transparency glass body is one of its most important features. It lets scientists see in real time how the resin color changes, how it swells, and how precipitates form. In old, opaque steel vessels, operators have to use offline HPLC sampling to check how well the couplings are working. This is a slow and expensive process that delays optimization. This problem is solved by the solid phase reactor, which gives constant visual feedback. This lets the chemical concentration, temperature, and stirring speed be changed right away. This feature is especially useful when creating new peptide conjugates and antibody-drug conjugates, because reaction rates can change greatly from batch to batch, and being able to see the results saves a lot of money on redo.
A European biopharmaceutical company developing a chiral API intermediate struggled with low crystallization yield and frequent cross-contamination during multi-step transfers between separate vessels. Metal-ion impurities from traditional steel reactors broke down enantiomeric excess below the 99 percent level needed for regulatory filing.
Bioland customized a 100 L solid phase reactor with integrated reaction-crystallization-filtration capability, eliminating all intermediate material transfers. During the reaction phase, operators used the transparent vessel to monitor color shifts under nitrogen at 0–5 °C, confirming complete conversion visually.
The crystallization stage employed jacket-controlled cooling at 1–2 °C per hour, producing uniform crystals free of impurity inclusions. Final PTFE filtration achieved 99.5 percent product purity with a 15 percent yield improvement over the previous multi-vessel process.
There is a big efficiency boost from using a solid phase reactor because it can combine several unit processes into one tank. Usually, after a synthesis reaction, the mixture is moved to a different crystallizer, then to a Nutsche filter, and finally to a dryer. Each move lowers the yield, increases the risk of contamination, and costs money in work. By doing the reaction, cooling-induced crystallization, and solid-liquid separation all in the same glass chamber, the solid phase reactor streamlines this whole process. The PTFE sintered disc at the base of the vessel filters quickly and lets you choose the size of the pores. The jacketed walls allow for precise cooling to cause supersaturation. This integrated method cuts the total time needed for processing by up to 40% and uses a lot less solvent.
The main thing that sets a solid phase reactor apart from a regular glass reactor is how well it filters. Bioland gives every solid phase reactor a standard PTFE sintered filter disc. If needed, customers can choose to upgrade to stainless steel or titanium filter elements, which are more chemically compatible. The large-diameter filter design makes the most of the filtering surface area, which lets the solvent leave quickly, even with fine-particle crystalline products that can't be seen by regular filter media. There are different types of filter cloth and membranes that can be used to match particle sizes from less than one micron to several hundred microns. Because it is so adaptable, the solid phase reactor can get back both large peptide-resin beads and small medicinal crystals.
For pharmaceutical manufacturing to be consistent from batch to batch, every process element must be carefully controlled. Bioland's solid phase reactor has a PLC-based control system with a touch-screen human-machine interface that lets you set the spinning speed and temperature settings. Operators can create multi-stage ramp-and-hold recipes that automatically change jacket fluid temperature and pump speed throughout the synthesis, crystallization, and filtering process. The large temperature range of -20 °C to 200 °C accommodates most pharmaceutical processes, ranging from low-temperature lithiation to high-temperature esterification. When paired with a stainless-steel heating-cooling fan, the solid phase reactor offers ±1 °C temperature stability that protects product quality and regulatory compliance.
Strong acid media caused a Polish chemical company that made palladium and platinum catalysts to have low recovery rates and equipment that rusted quickly. Solid-phase reactions at high temperatures made the catalyst less useful, and regular filtration systems got clogged within hours of use.
Bioland sent a custom 50 L solid phase reactor with borosilicate glass that can handle high temperatures and a quick-release PTFE filtration assembly. The solid phase reaction happened at 150 °C, and the glass body could handle the sudden change in temperature without losing its integrity as a catalyst.
After the reaction, the mother liquor was filtered through a large-diameter PTFE disc, which got back more than 90% of the precious metals. The design of the quick-disassembly filter cut cleaning time by 60% and got rid of all batch-to-batch contamination.
For clinical studies, regulatory bodies want peptide drugs that are made according to strict GMP rules. The solid phase reactor is built from the ground up to meet these needs. The Bioland solid phase reactor has borosilicate glass, PTFE seals, and PTFE filter media that are all wet. These surfaces are naturally cleanable, non-reactive, and free of impurities that can be extracted. Standard medicinal chemicals can be used to clean the jar in place, and the smooth glass interior keeps products from sticking together, which could trap leftover contaminants. With every solid phase reactor, Bioland includes full material traceability documentation, pressure-test certificates, and GMP validation support packages. This makes it easier for clients to submit their peptide therapeutics to the government, which speeds up the clinical phases.
Many peptide coupling reactions use flammable solvents like dichloromethane, acetonitrile, and DMF, which can create large-scale environments that could explode. Bioland's explosion-proof solid phase reactor complies with rigorous industrial safety standards, featuring flameproof motors, intrinsically safe temperature sensors, and anti-static grounding connections. The high-strength, pressure-rated glass body and precise, explosion-proof control system make it safe to use in 20 L, 30 L, 50 L, and 100 L amounts, even when the synthesis conditions are tough. Electric lifting mechanisms simplify head assembly removal for resin loading and product discharge, while the sealed PTFE agitation system prevents solvent vapor escape. In high-risk pharmaceutical environments, this complete safety architecture makes sure that the solid phase reactor protects both people and the integrity of the product.
Peptide production rarely involves a single reaction step; most therapeutic peptides require 10 to 50 repeated coupling-deprotection cycles, each with unique liquid and temperature requirements. The modular design of the Bioland solid phase reactor allows clients to configure the vessel with additional condensers, reagent addition ports, vacuum lines, and tail-gas absorption units as needed. Standard multi-neck flange lids can fit temperature probes, nitrogen inlets, and sampling valves without affecting the vacuum integrity of the vessel. This modularity means a single solid phase reactor can adapt to entirely different peptide sequences and synthesis strategies, maximizing equipment utilization and reducing the capital investment required for multi-product pilot facilities operating under tight development timelines.
No two biotech companies follow identical development pathways, and off-the-shelf equipment frequently fails to address specific process constraints. Bioland specializes in building a custom solid phase reactor suited to each client's unique requirements—whether that involves non-standard tank measurements, specialized filter media, integrated ultrasound probes, or fully automated PLC control with recipe management. OEM and ODM orders are accepted, with logos, paperwork, and interface customization available to match your company standards. Standard types of solid phase reactors are sent out within 5 to 7 business days, and fully personalized ones are usually finished in 30 business days. This responsiveness ensures that equipment procurement never delays your critical development milestones or regulatory filing deadlines.
The biotech and pharmaceutical businesses use a huge range of reaction conditions, from high-temperature polymerizations to cold molecular changes. With its dual-jacket design, the Bioland solid phase reactor can work at temperatures ranging from −20 °C to 200 °C. When paired with an external ultra-low-temperature pump, the range can go as low as −80 °C. This thermal flexibility allows a single solid phase reactor to handle peptide coupling at normal temperature, cold-induced crystallization at sub-zero conditions, and hot filtration at high temperatures—all within the same batch cycle. The customizable temperature driver automatically runs multi-step ramp rates. This makes sure that the solid phase reactor gives you consistent results, no matter how complicated your thermal process is.
While the solid phase reactor is indispensable for peptide drug development, its applications extend well beyond the pharmaceutical sector. In fine chemicals manufacturing, the solid phase reactor allows exact crystallization of colors, fragrances, and custom intermediates where crystal shape directly impacts product performance. In the precious metals business, the solid phase reactor makes it easier to make and recover catalysts in harsh conditions that would quickly destroy metal vessels made of other materials. In food processing, the solid phase reactor is used to clean sugar and crystallize amino acids. In new materials research, it is used for polymer-supported synthesis and functionalizing nanomaterials. Because it can be used in different industries, the solid phase reactor is a smart purchase that can help many R&D and production teams in a wide-ranging company.
When you buy a solid phase reactor, you're committing to it for a long time. Bioland backs up every unit with full lifecycle support that lasts long after the sale. For each order of a solid phase reactor, a project specialist is assigned to it. This person sends you weekly production updates with photos and videos to keep you up to date on everything that is going on during the manufacturing process. When it's done, full review media is sent to you for approval before it's shipped. Bioland's Xi'an facility also offers a Factory Acceptance Test that clients can use to check performance under simulated process conditions. Bioland guarantees that your solid phase reactor will work reliably for as long as it is operating with a one-year quality warranty, lifetime maintenance support, and service coverage that includes Europe, Southeast Asia, and the Americas.
The solid phase reactor is now an important tool for biotech and pharmaceutical companies that want to speed up the development of peptide drugs, improve the purity of crystallization, and streamline workflows that involve multiple steps. The solid phase reactor combines reaction, filtration, and crystallization into a single clear, corrosion-resistant vessel. This gets rid of the need for expensive transfers and contamination risks, while still meeting GMP standards at all scales. The solid phase reactor solutions that Xi'an Bioland Instrument Co., Ltd. offers solve real process problems and make measurable production improvements for clients around the world are backed by over 15 years of engineering experience, CE/ISO certification, competitive pricing, and full OEM/ODM customization.
A solid phase reactor integrates reaction, filtration, and crystallization for peptide synthesis, API purification, and catalyst recovery.
Standard PTFE sintered discs are included; stainless-steel, titanium, and custom membrane options are available.
Yes, Bioland offers explosion-proof solid phase reactor models with flameproof motors and intrinsically safe controls.
The standard range is −20 °C to 200 °C, extendable to −80 °C with an external circulator.
Custom orders ship in approximately 30 business days; standard models are ready in 5–7 days.
Is your team struggling with low crystallization yields, cross-contamination during multi-step transfers, or equipment corrosion from aggressive peptide synthesis solvents? Xi'an Bioland Instrument Co., Ltd. delivers high-performance solid phase reactor solutions engineered to solve these exact challenges. With CE/ISO certification, GMP compliance, and over 15 years of industry expertise, Bioland Instrument provides fully integrated reaction-filtration-crystallization platforms featuring PTFE filtration, explosion-proof safety, and programmable PLC control. We welcome OEM/ODM orders with rapid lead times and weekly production tracking. Contact our engineering team today for a free process consultation and discover how a custom solid phase reactor can boost your purity, yield, and throughput. Email us at info@biolandequip.com to get started.
1. Merrifield, R. B. Solid Phase Peptide Synthesis: The Synthesis of a Tetrapeptide, Journal of the American Chemical Society, vol. 85, no. 14, 1963.
2. Amblard, M., Fehrentz, J. A., Martinez, J., and Subra, G. Methods and Protocols of Modern Solid Phase Peptide Synthesis, Molecular Biotechnology, vol. 33, no. 3, 2006.
3. Behrendt, R., White, P., and Offer, J. Advances in Fmoc Solid-Phase Peptide Synthesis, Journal of Peptide Science, vol. 22, no. 1, 2016.
4. Myerson, A. S. Handbook of Industrial Crystallization, 2nd Edition, Butterworth-Heinemann, 2002.
5. Mullin, J. W. Crystallization, 4th Edition, Butterworth-Heinemann, 2001.
6. Bray, B. L. Large-Scale Manufacture of Peptide Therapeutics by Chemical Synthesis, Nature Reviews Drug Discovery, vol. 2, no. 7, 2003.
2024-05-16
Pharmaceutical Company
The reactor is beautifully mirror-polished and fully complies with GMP requirements for the pharmaceutical industry. The performance is excellent! Overall, we are very satisfied! We also provided with some feedback on our process improvements, which we hope will be helpful.
2024-04-09
Laboratory
Excellent and professional service. Always reply our questions very fast. All reactors and chiller we received are good too.
2024-02-15
Research Institute
Quality is beyond our expectation actually. After we got the extraction equipment and started using it, the performance was beyond our expectation. Very easy to use and very efficient to run. Service always respond us very quickly. Was also very helpful to help us. Thanks Bioland team. Very happy to work with you.
2023-11-20
Biotech Company
We are happy about the new purchase as always. Equipment and services are both good.
2023-08-05
Instrument Lab
This is the second order with Bioland instrument and everything is good as the first dateText.
2023-05-12
Global Trading Partner
Bioland instrument team is very helpful and professional. The sales helped us select the right equipment for our application, and their logistics people handled the transportation and customs declaration for our shipment. All that saved us a lot of work.
